Committees
Research conducted at the Center for Clinical Research and Translational Medicine (CIMeT) is evaluated and approved by a group of committees whose purpose is to determine the scientific, ethical, and methodological relevance of research activities. CIMeT committees are composed of researchers and professionals from different fields of knowledge who have the experience and training required to conduct a rigorous evaluation of research protocols.
The committees are responsible for ensuring compliance with the ethical provisions applicable to research involving human participants; the prevention and control of risks associated with the use of pathogenic microorganisms or biological material; and the relevance, quality, and consistency of the methodological design of projects submitted for evaluation.
To fulfill its duties and responsibilities, the Center for Clinical Research and Translational Medicine (CIMeT) has specialized committees responsible for the scientific, ethical, and biosafety evaluation of research protocols. These committees contribute to the development of responsible research and compliance with current national and international regulations.
Research Committee
The Research Committee of the Center for Clinical Research and Translational Medicine (CIMeT) evaluates, reviews, and issues decisions on research protocols submitted for consideration, verifying compliance with established scientific, technical, and methodological criteria. It also ensures that each project's objectives, design, and procedures are consistent, thereby safeguarding its feasibility and scientific quality.
The Committee conducts its activities in accordance with the ethical principles and regulatory requirements applicable to health research, including the Regulations of the General Health Law on Health Research and current national and international provisions governing the responsible conduct of research studies.
Research Committee Members
| Member | Role |
|---|---|
| Luis Miguel Román Pintos | Chair |
| Cesar Arturo Nava Valdivia | Secretary |
| José David Medina Preciado | Committee Member |
| Jhonatan Trujillo Quirós | Committee Member |
| Andrea Molina Pineda | Committee Member |
| Misael Caballero Sandoval | Committee Member |
Biosafety Committee
The Biosafety Committee of the Center for Clinical Research and Translational Medicine (CIMeT) evaluates, reviews, and issues decisions on research protocols involving the use, handling, or study of pathogenic microorganisms, biological agents, or materials that may pose a biological risk.
The Committee verifies that projects comply with the safety, containment, and prevention measures required to minimize risks associated with the handling of biological material. It also ensures that the potential benefits and risks of research activities are duly considered in accordance with applicable national and international biosafety regulations.
Biosafety Committee Members
| Member | Role |
|---|---|
| Andrea Molina Pineda | Chair |
| Misael Caballero Sandoval | Secretary |
| Jorge Eduardo Alvarado Aguilar | Committee Member |
| Esteban González Díaz | Committee Member |
| Sonia Sifuentes Franco | Committee Member |
| Sergio Ulises Zarate Reyes | Committee Member |
2026 Regular Session Calendar
Research Committee – Biosafety Committee – Research Ethics Committee
| Month | Dates | Time |
|---|---|---|
| January | Thursday, January 8 Thursday, January 22 | 7:00 p.m. (19:00) |
| February | Thursday, February 5 Thursday, February 19 | 7:00 p.m. (19:00) |
| March | Thursday, March 5 Thursday, March 19 | 7:00 p.m. (19:00) |
| April | Thursday, April 9 Thursday, April 23 | 7:00 p.m. (19:00) |
| May | Thursday, May 7 Thursday, May 21 | 7:00 p.m. (19:00) |
| June | Thursday, June 4 Thursday, June 18 | 7:00 p.m. (19:00) |
| July | Thursday, July 9 Thursday, July 23 | 7:00 p.m. (19:00) |
| August | Thursday, August 6 Thursday, August 20 | 7:00 p.m. (19:00) |
| September | Thursday, September 3 Thursday, September 17 | 7:00 p.m. (19:00) |
| October | Thursday, October 8 Thursday, October 22 | 7:00 p.m. (19:00) |
| November | Thursday, November 5 Thursday, November 19 | 7:00 p.m. (19:00) |
| December | Thursday, December 3 Thursday, December 17 | 7:00 p.m. (19:00) |
Sessions and Quorum
The COMMITTEE shall hold a regular session at least once every two months, according to its needs and workload. It may also hold an extraordinary or expedited session at any time at the request of its Chair.
The schedule and calendar of regular sessions shall be announced to interested parties in advance.
The agenda and documents for each session shall be delivered at least seven business days before the meeting. For extraordinary sessions, they shall be delivered three days in advance.
The minimum number of members required to establish a quorum shall be more than 50% of the Committee's members and must include the Chair and/or Secretary. Otherwise, the session shall be postponed until the next scheduled meeting.
The Chair and/or Secretary must be present as part of the minimum membership required to establish a quorum. A COMMITTEE session may not begin without their presence.
At the COMMITTEE's discretion, the investigator may be invited to present the proposal or provide further information on specific aspects of it.
Minutes shall be prepared for every session and shall specify the minutes number, date, and type of meeting: regular, extraordinary, or expedited.
Regular Sessions
The COMMITTEE shall meet weekly at scheduled meetings. A maximum of five new studies may be reviewed and decided upon during each scheduled session.
Extraordinary Sessions
These sessions shall be held upon an express request and in response to circumstances involving the COMMITTEE's activities, investigators, participants, or the institution. They shall be convened by the Chair.
Expedited Meetings
These meetings shall be held to address administrative changes, the registration of new investigators, date changes, notifications, and clarifications that do not substantially affect the studies, among other matters.
eKomite
Access eKomite to register and submit protocols, documents, and requests for evaluation by the institutional committees.
Access eKomiteContact
If you need additional information about the submission process or the institutional committees, please use the following contact information:
Dr. Kevin Gonzalez
850 Sierra Nevada, Col. Independencia, Postal Code 44340, Guadalajara, Jalisco, Mexico.
Requirements for Submission to the Committees
Before initiating any procedure or Initial Review submission, the provider must formally demonstrate that it has begun the registration process with the Committees of the Center for Clinical Research and Translational Medicine (CIMeT) by submitting the appropriate proof to the Committees Secretary at: irb@cimetscientific.com .
Any review by a Committee requires the Principal Investigator to submit a written request on the institution's letterhead, addressed to the Committee Chair, containing:
- Clinical protocol number and title.
- Investigator's full name.
- Legal name of the research site.
- Research site address.
- A clearly detailed subject.
- A list of the documents to be reviewed.
- All documents listed in the Submission Letter.
- The request must be delivered at least five business days before each review session.
1 Initial Review
- Submission Letter.
- Documents listed in the Submission Letter.
- Principal Investigator's curriculum vitae.
- Copy of the professional license.
- Copy of the Principal Investigator's degree or diploma.
- Copy of the Principal Investigator's Good Clinical Practice certificate.
- Site Notice of Operation or Health License.
- Site Facilities Description Letter.
- Hospital agreement for emergency medical care, when applicable.
- Insurance policy covering damages.
- Conflict of Interest Declaration.
- Declaration Letter in which the Investigator confirms that the protocol has not previously been submitted to another Committee and does not have a current registration at the Research Center.
2 Initial Review Following Transfer of Rights
- All documents required for an Initial Review.
- Report on the current status of study participants.
-
Transfer of Rights Letter issued by the current reviewing
Committee or, alternatively, by the Principal Investigator,
including:
- Name of the current reviewing Committee Chair.
- Name of the current Committee and institution.
- Protocol number and title.
- Name of the Principal Investigator.
- Legal name of the research site.
- Site address.
- Site telephone number.
3 Subsequent Submissions and Notifications
- Submission Letter.
- Documents listed in the letter.
4 Expedited Review Request
- Additional fee.
- Documents must be delivered three business days before the session.
5 Follow-up Reports and/or Annual Reapproval
- Submission Letter.
- Follow-up Report Form.
6 Request for Transfer of Rights
-
Request Letter including:
- Information about the new reviewing Committee: name of the Chair and name of the Committee.
- Information about the study, site, and Principal Investigator.
- Report on the current status of study participants.
7 Study Closure
-
Study Closure Notification Letter including:
- Final status report for study participants.
- Date of the Sponsor's closeout visit.
- Letter or communication from the Study Sponsor.
- Final Technical Report submitted to COFEPRIS.
8 Premature Study Closure
- Study Closure Notification Letter explaining why the site did not recruit any participants.
9 Change of Site Address
- Notification Letter.
- New Notice of Operation and/or Health License.
10 Change of Principal Investigator
- Transfer of Responsibility Letter from the current Investigator.
- Acceptance of Responsibility Letter from the new Investigator.
- Curriculum vitae of the new Principal Investigator.
- Copy of the new Principal Investigator's professional license.
- Copy of the new Principal Investigator's degree or diploma.
- Copy of the new Principal Investigator's Good Clinical Practice certificate.
- Procedure for notifying study participants of the change.
CIMeT Committees use eKomite®, a digital platform for online submissions. You may register and submit your documents at:
Submit through eKomite